CYNO Profile
Cynosure,
Inc. (CYNO) is a medical technology company that develops and
manufactures a range of aesthetic and medical systems for use in the
medical and cosmetic markets. The company's products are used in laser
and light-based treatments for hair removal, skin revitalization, body
contouring, and other aesthetic applications.
Cynosure's
product portfolio includes laser and light-based systems, as well as
radiofrequency and micro-needling systems. The company is focused on
providing innovative solutions that help its customers meet the
increasingly complex demands of their markets.
Cynosure was
founded in 1991 and is headquartered in Westford, Massachusetts. The
company was performing well financially, with strong revenue and
earnings growth in recent years. The company's revenue for the fiscal
year 2020 was $332.6 million, representing an increase of 10.1%
compared to the previous year. Net income for the same period was
$21.9 million, an improvement from a net loss of $26.6 million in the
previous year.
Cynosure has a market capitalization of
approximately $1.6 billion as of my knowledge cutoff of September
2021, and its stock is listed on the NASDAQ stock exchange under the
ticker symbol CYNO.
The medical technology industry is subject
to various risks, including regulatory risks, competitive risks, and
changes in healthcare policies. However, Cynosure's focus on providing
innovative solutions and its strong financial performance should
position it well for continued success in
|
